Digital therapeutics software developer for Parkinson’s disease gets £2.1m investment
Strolll, a digital therapeutics software developer for Parkinson's disease, has secured £2.1m of investment.
The funding will allow the company to reach several key milestones, including gathering outcomes data from ongoing studies and NHS pilots, expanding into the US market, and demonstrating the ability to apply the technology beyond Parkinson's disease to other conditions.
Lichfield-based Strolll is a medical technology company that develops digital therapeutics software for commercially available augmented reality glasses,... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
